Immunochemistry with the F19 antibody (mouse anti-human FAP) was performed in human coronaries from patients with no significant coronary disease (CAD), as well as mild, moderate, and advanced CAD in the left anterior descending artery. This evidence concerns the gene FAP and coronary artery disorder.